Tag: Inc. ARIA

  • Top Gainers: Ariad Pharmaceuticals (NASDAQ:ARIA), Idera Pharmaceuticals (NASDAQ:IDRA), Halcon Resources (NYSE:HK), GameStop (NYSE:GME)

    Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares gained 6.18% to $8.07. The company on Mar. 24 announced the initiation of a pivotal global Phase 2 trial of AP26113 in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who were previously treated with crizotinib. The ALTA (ALK in Lung Cancer Trial of AP26113) trial is designed to determine the safety and efficacy of AP26113 in refractory NSCLC patients who test positive for the anaplastic lymphoma kinase (ALK+) oncogene. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares after opening at $8.04 moved to $8.20 on last trade day and at the end of the day closed at $7.98. Company price to sales ratio in past twelve months was calculated as 32.50 and price to cash ratio as 6.25. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) showed a positive weekly performance of 1.79%.

    Shares of Idera Pharmaceuticals Inc (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing DNA- and RNA-based therapies, jumped by as much as 22% after announcing positive top-line data from its midstage study of IMO-8400 as a treatment for moderate-to-severe plaque psoriasis. Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares advanced 17.78% in last trading session and ended the day on $4.57. Idera Pharmaceuticals Inc (NASDAQ:IDRA) return on equity ratio is recorded as -444.00% and its return on assets is -114.30%. Idera Pharmaceuticals Inc (NASDAQ:IDRA) yearly performance is 814.00%.

    Halcon Resources Corp (NYSE:HK) has announced that it will wait and watch out for the results from Ohio’s Utica shale and take up a decision to carry on further drilling in the region. According to company’s Chairman and CEO, Floyd C. Wilson, the production results were not up to the expectations and Utica’s output is not considered in the current year’s production out come. The company will wait further and watch out for the results and decide accordingly on further course of action. Halcon Resources Corp (NYSE:HK) has about 139,000 acres in the Utica play, including in western Pennsylvania. The company has 11 horizontal well permits in eastern Ohio and according to data from Ohio Department of Natural Resources, Halcon Resources has one well in Mahoning County and three in Trumbull County which are producing and rest of the well are in the state of readiness. Ohio’s Utica shale was note listed by the company in fourth-quarter results and it is moved to non-core assets and the company will reduce it focus on this region and shift it focus towards Tuscaloosa Marine Shale in Louisiana and Mississippi, where it has acquired 307,000 acres. The company also has plans to divest its non-core assets in eastern Texas for $450 million, which leads to speculation that Utica could also be part of it. However, the company has indicated Utica’s lease will not expire soon and they have no plans of divesting it as of now. Halcon Resources Corp (NYSE:HK) shares moved up 5.61% in last trading session and was closed at $4.14, while trading in range of $ 3.94 – 4.15. Halcon Resources Corp (NYSE:HK) year to date (YTD) performance is 7.25%.

    The yearend and the fourth quarter report for the fiscal year which ended on February 1, 2014 have been announced by GameStop Corp. (NYSE:GME) a multichannel video game, wireless and consumer electronic services retailer, GME has reported the company’s progress and economic status for the last financial year. Paul Raines, the chief executive officer of GME has stated that the year 2013 had many new consoles brought into the market by the company which increased the shares of the company to an all time high. He also suggested solid growth of the company in the wireless and consumer electronics market for the coming year 2014. GameStop Corp.(NYSE:GME) weekly performance is 7.40%. On last trading day company shares ended up $40.62. GameStop Corp.(NYSE:GME) distance from 50-day simple moving average (SMA50) is 10.32%. Analysts mean target price for the company is $50.60.